导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 12.54% | 724/4773 |
| 近一周 | 0.29% | 660/5465 |
| 近一月 | -6.58% | 4234/5421 |
| 近一季 | -12.09% | 4012/5231 |
| 近半年 | 12.25% | 483/4920 |
| 近一年 | 16.57% | 729/4394 |
| 近两年 | 176.58% | 137/2954 |
| 近三年 | 127.14% | 64/2253 |
| 成立以来 | 52.17% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.39% 4120/4961 |
55.21% 493/5312 |
- - |
- - |
| 2025 | 68.57% 139/4813 |
5.15% 814/3635 |
1.46% 2323/4076 |
58.86% 139/4524 |
-0.54% 2531/4813 |
| 2024 | 20.91% 430/3463 |
-1.76% 1272/2808 |
-3.01% 1287/3014 |
15.38% 1729/3129 |
9.98% 294/3463 |
| 2023 | 11.72% 66/2656 |
38.88% 33/2280 |
-2.91% 708/2385 |
-14.42% 2184/2515 |
-3.18% 623/2655 |
| 2022 | -34.46% 1717/2207 |
-20.35% 1540/1919 |
-3.62% 1831/2016 |
-20.56% 1862/2113 |
7.48% 306/2208 |
| 2021 | 8.33% 480/1822 |
-6.52% 1012/1255 |
13.71% 278/1330 |
-8.32% 1127/1466 |
11.16% 91/1822 |
| 2020 | - - |
- - |
- - |
- - |
-1.40% 1105/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4546 | 31.90% |
| 华富中证港股通创新药指数型发起式A | 1.1637 | 30.96% |
| 天弘恒生沪深港创新药精选50ETF发起联接A | 1.3128 | 30.52% |
| 中欧中证港股通创新药指数发起A | 1.6103 | 30.52% |
| 嘉实中证港股通创新药指数发起式C | 0.8566 | 30.50% |
| 中欧中证港股通创新药指数发起C | 1.4583 | 30.44% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8927 | 30.26% |
| 景顺长城中证港股通创新药ETF联接C | 1.4696 | 29.97% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8736 | 29.94% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8719 | 29.88% |
| 易方达中证人工智能主题ETF VS. 长安沪深300非周期A(740101) |